AngioDynamics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
AngioDynamics, Inc. (ANGO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) of $33.00 thousand for the 12-month period ending 2019-05-31, per its 10-K filed 2020-08-10.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss · last filed 2020-08-10
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2019-05-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2018-05-31 was $36.00K.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2018-02-28 was $21.00K.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2017-11-30 was $45.00K, a 650.00% increase year-over-year.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2019 was $33.00K, a 67.65% decline from fiscal 2018.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2018 was $102.00K.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2015 was -$120.00K.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2014 was -$41.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2019-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $33.00K 10-K · filed 2020-08-10 | |||
| 2019-02-28 | $33.00K 10-Q · filed 2019-04-02 | ||||
| 2018-05-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25 | $57.00K derived: sum of 2 quarters · filed 2019-07-25 | $102.00K derived: sum of 3 quarters · filed 2019-07-25 | $102.00K 10-K · filed 2019-07-25 | |
| 2018-02-28 | $21.00K 10-Q · filed 2018-04-05 | $66.00K derived: sum of 2 quarters · filed 2018-04-05 | $66.00K 10-Q · filed 2018-04-05 | ||
| 2017-11-30 | $45.00K 10-Q · filed 2018-01-05 | $45.00K 10-Q · filed 2018-01-05 | |||
| 2016-11-30 | $6.00K 10-Q · filed 2017-01-06 | $0.00 derived: sum of 2 quarters · filed 2017-01-06 | |||
| 2016-08-31 | -$6.00K 10-Q · filed 2016-10-05 | ||||
| 2016-02-29 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-11 | -$1.00K derived: sum of 2 quarters · filed 2016-04-11 | $2.00K 10-Q · filed 2016-04-11 | $9.00K derived: sum of 4 quarters · filed 2016-08-01 | |
| 2015-11-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | -$25.00K 10-Q · filed 2016-01-08 | -$18.00K derived: sum of 3 quarters · filed 2016-08-01 | -$34.00K derived: sum of 4 quarters · filed 2016-08-01 | |
| 2015-08-31 | $3.00K 10-Q · filed 2015-10-08 | $10.00K derived: sum of 2 quarters · filed 2016-08-01 | -$6.00K derived: sum of 3 quarters · filed 2016-08-01 | $22.00K derived: sum of 4 quarters · filed 2016-08-01 | |
| 2015-05-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | -$9.00K derived: sum of 2 quarters · filed 2016-08-01 | $19.00K derived: sum of 3 quarters · filed 2016-08-01 | -$120.00K 10-K · filed 2016-08-01 | |
| 2015-02-28 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-09 | $12.00K derived: sum of 2 quarters · filed 2015-04-09 | -$127.00K 10-Q · filed 2015-04-09 | -$186.00K derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-11-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$111.00K 10-Q · filed 2015-01-09 | -$170.00K derived: sum of 3 quarters · filed 2015-08-10 | ||
| 2014-08-31 | -$139.00K 10-Q · filed 2014-10-15 | -$198.00K derived: sum of 2 quarters · filed 2015-08-10 | |||
| 2014-05-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10 | -$41.00K 10-K · filed 2015-08-10 | -$16.00K 10-K · filed 2014-08-14 | ||
| 2014-02-28 | $18.00K 10-Q · filed 2014-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |